LEONARDA-2: Lerociclib plus letrozole versus placebo plus letrozole in HR+/HER2- advanced or metastatic breast cancer.Xichun Hu, Biyun Wang, Shusen Wang et al.|Journal of Clinical Oncology|2024Cited by 1
Analysis of Clinical Characteristics and EGFR Gene Status in Uyghurs with Lung Cancer in Xinjiang, ChinaGuomin Gu, Kahaer Jiang, Bing Zhao et al.|Medical Science and Technology|2015Cited by 0